APO Research
Talk to an analyst

APO RESEARCH · REPORT

PEPs and Sanction Screening

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global PEPs and Sanction Screening Market Analysis and Forecast 2026-2032

11 April 2026216 pages

Choose your research edition.

Industry ResearchPEPs and Sanction Screening Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal PEPs and Sanction Screening Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal PEPs and Sanction Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PEPs and Sanction Screening Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal PEPs and Sanction Screening Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global PEPs and Sanction Screening market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for PEPs and Sanction Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for PEPs and Sanction Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for PEPs and Sanction Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for PEPs and Sanction Screening is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of PEPs and Sanction Screening include IDnow, Jumio, Persona, Entrust, Smile ID, Veriff, Trulioo, GBG Plc and Sumsub, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for PEPs and Sanction Screening, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of PEPs and Sanction Screening, also provides the revenue of main regions and countries. Of the upcoming market potential for PEPs and Sanction Screening, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PEPs and Sanction Screening revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global PEPs and Sanction Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for PEPs and Sanction Screening revenue, projected growth trends, production technology, application and end-user industry.

PEPs and Sanction Screening Segment by Company

IDnow

Jumio

Persona

Entrust

Smile ID

Veriff

Trulioo

GBG Plc

Sumsub

Ondato

NameScan

Castellum.AI

Dotfile

RELX (LexisNexis)

Owlin

Dilisense GmbH

Fenergo

Thirdfort

Experian

AU10TIX

PEPs and Sanction Screening Segment by Type

Software

Service

PEPs and Sanction Screening Segment by Application

BFSI

iGaming

Payments

eCommerce

Other

PEPs and Sanction Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PEPs and Sanction Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PEPs and Sanction Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PEPs and Sanction Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of PEPs and Sanction Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of PEPs and Sanction Screening company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PEPs and Sanction Screening revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global PEPs and Sanction Screening Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Software Major Player Table 3. Service Major Player Table 4. Global PEPs and Sanction Screening Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. BFSI Major Player Table 6. iGaming Major Player Table 7. Payments Major Player Table 8. eCommerce Major Player Table 9. Other Major Player Table 10. PEPs and Sanction Screening Industry Trends Table 11. PEPs and Sanction Screening Industry Drivers Table 12. PEPs and Sanction Screening Industry Opportunities and Challenges Table 13. PEPs and Sanction Screening Industry Restraints Table 14. Global PEPs and Sanction Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global PEPs and Sanction Screening Market Size by Region (2021-2026) & (US$ Million) Table 16. Global PEPs and Sanction Screening Market Share by Region (2021-2026) Table 17. Global PEPs and Sanction Screening Market Size by Region (2027-2032) & (US$ Million) Table 18. Global PEPs and Sanction Screening Market Share by Region (2027-2032) Table 19. Global PEPs and Sanction Screening Revenue by Players (US$ Million) & (2021-2026) Table 20. Global PEPs and Sanction Screening Revenue Market Share by Players (2021-2026) Table 21. Global PEPs and Sanction Screening Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global PEPs and Sanction Screening Key Players Headquarters & Area Served Table 23. Global PEPs and Sanction Screening Players, Product Type & Application Table 24. Global PEPs and Sanction Screening Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global PEPs and Sanction Screening by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global PEPs and Sanction Screening Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global PEPs and Sanction Screening Revenue by Type (2021-2026) & (US$ Million) Table 29. Global PEPs and Sanction Screening Revenue by Type (2027-2032) & (US$ Million) Table 30. Global PEPs and Sanction Screening Revenue Market Share by Type (2021-2026) Table 31. Global PEPs and Sanction Screening Revenue Market Share by Type (2027-2032) Table 32. Global PEPs and Sanction Screening Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global PEPs and Sanction Screening Revenue by Application (2021-2026) & (US$ Million) Table 34. Global PEPs and Sanction Screening Revenue by Application (2027-2032) & (US$ Million) Table 35. Global PEPs and Sanction Screening Revenue Market Share by Application (2021-2026) Table 36. Global PEPs and Sanction Screening Revenue Market Share by Application (2027-2032) Table 37. IDnow Company Information Table 38. IDnow Business Overview Table 39. IDnow PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. IDnow PEPs and Sanction Screening Product Portfolio Table 41. IDnow Recent Development Table 42. Jumio Company Information Table 43. Jumio Business Overview Table 44. Jumio PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Jumio PEPs and Sanction Screening Product Portfolio Table 46. Jumio Recent Development Table 47. Persona Company Information Table 48. Persona Business Overview Table 49. Persona PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Persona PEPs and Sanction Screening Product Portfolio Table 51. Persona Recent Development Table 52. Entrust Company Information Table 53. Entrust Business Overview Table 54. Entrust PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Entrust PEPs and Sanction Screening Product Portfolio Table 56. Entrust Recent Development Table 57. Smile ID Company Information Table 58. Smile ID Business Overview Table 59. Smile ID PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Smile ID PEPs and Sanction Screening Product Portfolio Table 61. Smile ID Recent Development Table 62. Veriff Company Information Table 63. Veriff Business Overview Table 64. Veriff PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Veriff PEPs and Sanction Screening Product Portfolio Table 66. Veriff Recent Development Table 67. Trulioo Company Information Table 68. Trulioo Business Overview Table 69. Trulioo PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Trulioo PEPs and Sanction Screening Product Portfolio Table 71. Trulioo Recent Development Table 72. GBG Plc Company Information Table 73. GBG Plc Business Overview Table 74. GBG Plc PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. GBG Plc PEPs and Sanction Screening Product Portfolio Table 76. GBG Plc Recent Development Table 77. Sumsub Company Information Table 78. Sumsub Business Overview Table 79. Sumsub PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Sumsub PEPs and Sanction Screening Product Portfolio Table 81. Sumsub Recent Development Table 82. Ondato Company Information Table 83. Ondato Business Overview Table 84. Ondato PEPs and Sanction Screening Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Ondato PEPs and Sanction Screening Product Portfolio Table 86. Ondato Recent Development Table 87. NameScan Company Information Table 88. NameScan Business Overview Table 89. NameScan PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. NameScan PEPs and Sanction Screening Product Portfolio Table 91. NameScan Recent Development Table 92. Castellum.AI Company Information Table 93. Castellum.AI Business Overview Table 94. Castellum.AI PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Castellum.AI PEPs and Sanction Screening Product Portfolio Table 96. Castellum.AI Recent Development Table 97. Dotfile Company Information Table 98. Dotfile Business Overview Table 99. Dotfile PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Dotfile PEPs and Sanction Screening Product Portfolio Table 101. Dotfile Recent Development Table 102. RELX (LexisNexis) Company Information Table 103. RELX (LexisNexis) Business Overview Table 104. RELX (LexisNexis) PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. RELX (LexisNexis) PEPs and Sanction Screening Product Portfolio Table 106. RELX (LexisNexis) Recent Development Table 107. Owlin Company Information Table 108. Owlin Business Overview Table 109. Owlin PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Owlin PEPs and Sanction Screening Product Portfolio Table 111. Owlin Recent Development Table 112. Dilisense GmbH Company Information Table 113. Dilisense GmbH Business Overview Table 114. Dilisense GmbH PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Dilisense GmbH PEPs and Sanction Screening Product Portfolio Table 116. Dilisense GmbH Recent Development Table 117. Fenergo Company Information Table 118. Fenergo Business Overview Table 119. Fenergo PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Fenergo PEPs and Sanction Screening Product Portfolio Table 121. Fenergo Recent Development Table 122. Thirdfort Company Information Table 123. Thirdfort Business Overview Table 124. Thirdfort PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Thirdfort PEPs and Sanction Screening Product Portfolio Table 126. Thirdfort Recent Development Table 127. Experian Company Information Table 128. Experian Business Overview Table 129. Experian PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Experian PEPs and Sanction Screening Product Portfolio Table 131. Experian Recent Development Table 132. AU10TIX Company Information Table 133. AU10TIX Business Overview Table 134. AU10TIX PEPs and Sanction Screening Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. AU10TIX PEPs and Sanction Screening Product Portfolio Table 136. AU10TIX Recent Development Table 137. North America PEPs and Sanction Screening Revenue by Type (2021-2026) & (US$ Million) Table 138. North America PEPs and Sanction Screening Revenue by Type (2027-2032) & (US$ Million) Table 139. North America PEPs and Sanction Screening Revenue by Application (2021-2026) & (US$ Million) Table 140. North America PEPs and Sanction Screening Revenue by Application (2027-2032) & (US$ Million) Table 141. North America PEPs and Sanction Screening Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America PEPs and Sanction Screening Revenue by Country (2021-2026) & (US$ Million) Table 143. North America PEPs and Sanction Screening Revenue by Country (US$ Million) & (2027-2032) Table 144. Europe PEPs and Sanction Screening Revenue by Type (2021-2026) & (US$ Million) Table 145. Europe PEPs and Sanction Screening Revenue by Type (2027-2032) & (US$ Million) Table 146. Europe PEPs and Sanction Screening Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe PEPs and Sanction Screening Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe PEPs and Sanction Screening Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe PEPs and Sanction Screening Revenue by Country (2021-2026) & (US$ Million) Table 150. Europe PEPs and Sanction Screening Revenue by Country (US$ Million) & (2027-2032) Table 151. China PEPs and Sanction Screening Revenue by Type (2021-2026) & (US$ Million) Table 152. China PEPs and Sanction Screening Revenue by Type (2027-2032) & (US$ Million) Table 153. China PEPs and Sanction Screening Revenue by Application (2021-2026) & (US$ Million) Table 154. China PEPs and Sanction Screening Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia PEPs and Sanction Screening Revenue by Type (2021-2026) & (US$ Million) Table 156. Asia PEPs and Sanction Screening Revenue by Type (2027-2032) & (US$ Million) Table 157. Asia PEPs and Sanction Screening Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia PEPs and Sanction Screening Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia PEPs and Sanction Screening Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia PEPs and Sanction Screening Revenue by Region (US$ Million) & (2021-2026) Table 161. Asia PEPs and Sanction Screening Revenue by Region (US$ Million) & (2027-2032) Table 162. SAMEA PEPs and Sanction Screening Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA PEPs and Sanction Screening Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA PEPs and Sanction Screening Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA PEPs and Sanction Screening Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA PEPs and Sanction Screening Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA PEPs and Sanction Screening Revenue by Country (2021-2026) & (US$ Million) Table 168. SAMEA PEPs and Sanction Screening Revenue by Country (US$ Million) & (2027-2032) Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. PEPs and Sanction Screening Image Figure 2. Global PEPs and Sanction Screening Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PEPs and Sanction Screening Market Size Share 2021 VS 2025 VS 2032 Figure 4. Software Image Figure 5. Service Image Figure 6. Global PEPs and Sanction Screening Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global PEPs and Sanction Screening Market Size Share 2021 VS 2025 VS 2032 Figure 8. BFSI Image Figure 9. iGaming Image Figure 10. Payments Image Figure 11. eCommerce Image Figure 12. Other Image Figure 13. Global PEPs and Sanction Screening Market Size (US$ Million) & (2021-2032) Figure 14. Global PEPs and Sanction Screening Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global PEPs and Sanction Screening Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global PEPs and Sanction Screening Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global PEPs and Sanction Screening Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global PEPs and Sanction Screening Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global PEPs and Sanction Screening Revenue Market Share by Type (2021-2032) Figure 21. Global PEPs and Sanction Screening Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global PEPs and Sanction Screening Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global PEPs and Sanction Screening Revenue Market Share by Application (2021-2032) Figure 24. North America PEPs and Sanction Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America PEPs and Sanction Screening Revenue Share by Type (2021-2032) Figure 26. North America PEPs and Sanction Screening Revenue Share by Application (2021-2032) Figure 27. North America PEPs and Sanction Screening Revenue Share by Country (2021-2032) Figure 28. United States PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe PEPs and Sanction Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe PEPs and Sanction Screening Revenue Share by Type (2021-2032) Figure 33. Europe PEPs and Sanction Screening Revenue Share by Application (2021-2032) Figure 34. Europe PEPs and Sanction Screening Revenue Share by Country (2021-2032) Figure 35. Germany PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China PEPs and Sanction Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China PEPs and Sanction Screening Revenue Share by Type (2021-2032) Figure 45. China PEPs and Sanction Screening Revenue Share by Application (2021-2032) Figure 46. Asia PEPs and Sanction Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia PEPs and Sanction Screening Revenue Share by Type (2021-2032) Figure 48. Asia PEPs and Sanction Screening Revenue Share by Application (2021-2032) Figure 49. Asia PEPs and Sanction Screening Revenue Share by Region (2021-2032) Figure 50. Japan PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA PEPs and Sanction Screening Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA PEPs and Sanction Screening Revenue Share by Type (2021-2032) Figure 58. SAMEA PEPs and Sanction Screening Revenue Share by Application (2021-2032) Figure 59. SAMEA PEPs and Sanction Screening Revenue Share by Country (2021-2032) Figure 60. Brazil PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt PEPs and Sanction Screening Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Software
  • Service
Applications
  • BFSI
  • iGaming
  • Payments
  • eCommerce
  • Other
Companies covered
  • IDnow
  • Jumio
  • Persona
  • Entrust
  • Smile ID
  • Veriff
  • Trulioo
  • GBG Plc
  • Sumsub
  • Ondato
  • NameScan
  • Castellum.AI
  • Dotfile
  • RELX (LexisNexis)
  • Owlin
  • Dilisense GmbH
  • Fenergo
  • Thirdfort
  • Experian
  • AU10TIX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 PEPs and Sanction Screening Market by Type
  3. 1.2.1 Global PEPs and Sanction Screening Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Software
  5. 1.2.3 Service
  6. 1.3 PEPs and Sanction Screening Market by Application
  7. 1.3.1 Global PEPs and Sanction Screening Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 BFSI
  9. 1.3.3 iGaming
  10. 1.3.4 Payments
  11. 1.3.5 eCommerce
  12. 1.3.6 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 PEPs and Sanction Screening Market Dynamics
  1. 2.1 PEPs and Sanction Screening Industry Trends
  2. 2.2 PEPs and Sanction Screening Industry Drivers
  3. 2.3 PEPs and Sanction Screening Industry Opportunities and Challenges
  4. 2.4 PEPs and Sanction Screening Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global PEPs and Sanction Screening Market Perspective (2021-2032)
  2. 3.2 Global PEPs and Sanction Screening Growth Trends by Region
  3. 3.2.1 Global PEPs and Sanction Screening Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global PEPs and Sanction Screening Market Size by Region (2021-2026)
  5. 3.2.3 Global PEPs and Sanction Screening Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global PEPs and Sanction Screening Revenue by Players
  2. 4.1.1 Global PEPs and Sanction Screening Revenue by Players (2021-2026)
  3. 4.1.2 Global PEPs and Sanction Screening Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global PEPs and Sanction Screening Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global PEPs and Sanction Screening Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global PEPs and Sanction Screening Key Players Headquarters & Area Served
  7. 4.4 Global PEPs and Sanction Screening Players, Product Type & Application
  8. 4.5 Global PEPs and Sanction Screening Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global PEPs and Sanction Screening Market CR5 and HHI
  11. 4.6.3 2025 PEPs and Sanction Screening Tier 1, Tier 2, and Tier 3
5 PEPs and Sanction Screening Market Size by Type
  1. 5.1 Global PEPs and Sanction Screening Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global PEPs and Sanction Screening Revenue by Type (2021-2032)
  3. 5.3 Global PEPs and Sanction Screening Revenue Market Share by Type (2021-2032)
6 PEPs and Sanction Screening Market Size by Application
  1. 6.1 Global PEPs and Sanction Screening Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global PEPs and Sanction Screening Revenue by Application (2021-2032)
  3. 6.3 Global PEPs and Sanction Screening Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 IDnow
  2. 7.1.1 IDnow Company Information
  3. 7.1.2 IDnow Business Overview
  4. 7.1.3 IDnow PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  5. 7.1.4 IDnow PEPs and Sanction Screening Product Portfolio
  6. 7.1.5 IDnow Recent Developments
  7. 7.2 Jumio
  8. 7.2.1 Jumio Company Information
  9. 7.2.2 Jumio Business Overview
  10. 7.2.3 Jumio PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Jumio PEPs and Sanction Screening Product Portfolio
  12. 7.2.5 Jumio Recent Developments
  13. 7.3 Persona
  14. 7.3.1 Persona Company Information
  15. 7.3.2 Persona Business Overview
  16. 7.3.3 Persona PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Persona PEPs and Sanction Screening Product Portfolio
  18. 7.3.5 Persona Recent Developments
  19. 7.4 Entrust
  20. 7.4.1 Entrust Company Information
  21. 7.4.2 Entrust Business Overview
  22. 7.4.3 Entrust PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Entrust PEPs and Sanction Screening Product Portfolio
  24. 7.4.5 Entrust Recent Developments
  25. 7.5 Smile ID
  26. 7.5.1 Smile ID Company Information
  27. 7.5.2 Smile ID Business Overview
  28. 7.5.3 Smile ID PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Smile ID PEPs and Sanction Screening Product Portfolio
  30. 7.5.5 Smile ID Recent Developments
  31. 7.6 Veriff
  32. 7.6.1 Veriff Company Information
  33. 7.6.2 Veriff Business Overview
  34. 7.6.3 Veriff PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Veriff PEPs and Sanction Screening Product Portfolio
  36. 7.6.5 Veriff Recent Developments
  37. 7.7 Trulioo
  38. 7.7.1 Trulioo Company Information
  39. 7.7.2 Trulioo Business Overview
  40. 7.7.3 Trulioo PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Trulioo PEPs and Sanction Screening Product Portfolio
  42. 7.7.5 Trulioo Recent Developments
  43. 7.8 GBG Plc
  44. 7.8.1 GBG Plc Company Information
  45. 7.8.2 GBG Plc Business Overview
  46. 7.8.3 GBG Plc PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GBG Plc PEPs and Sanction Screening Product Portfolio
  48. 7.8.5 GBG Plc Recent Developments
  49. 7.9 Sumsub
  50. 7.9.1 Sumsub Company Information
  51. 7.9.2 Sumsub Business Overview
  52. 7.9.3 Sumsub PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sumsub PEPs and Sanction Screening Product Portfolio
  54. 7.9.5 Sumsub Recent Developments
  55. 7.10 Ondato
  56. 7.10.1 Ondato Company Information
  57. 7.10.2 Ondato Business Overview
  58. 7.10.3 Ondato PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Ondato PEPs and Sanction Screening Product Portfolio
  60. 7.10.5 Ondato Recent Developments
  61. 7.11 NameScan
  62. 7.11.1 NameScan Company Information
  63. 7.11.2 NameScan Business Overview
  64. 7.11.3 NameScan PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  65. 7.11.4 NameScan PEPs and Sanction Screening Product Portfolio
  66. 7.11.5 NameScan Recent Developments
  67. 7.12 Castellum.AI
  68. 7.12.1 Castellum.AI Company Information
  69. 7.12.2 Castellum.AI Business Overview
  70. 7.12.3 Castellum.AI PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Castellum.AI PEPs and Sanction Screening Product Portfolio
  72. 7.12.5 Castellum.AI Recent Developments
  73. 7.13 Dotfile
  74. 7.13.1 Dotfile Company Information
  75. 7.13.2 Dotfile Business Overview
  76. 7.13.3 Dotfile PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Dotfile PEPs and Sanction Screening Product Portfolio
  78. 7.13.5 Dotfile Recent Developments
  79. 7.14 RELX (LexisNexis)
  80. 7.14.1 RELX (LexisNexis) Company Information
  81. 7.14.2 RELX (LexisNexis) Business Overview
  82. 7.14.3 RELX (LexisNexis) PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  83. 7.14.4 RELX (LexisNexis) PEPs and Sanction Screening Product Portfolio
  84. 7.14.5 RELX (LexisNexis) Recent Developments
  85. 7.15 Owlin
  86. 7.15.1 Owlin Company Information
  87. 7.15.2 Owlin Business Overview
  88. 7.15.3 Owlin PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Owlin PEPs and Sanction Screening Product Portfolio
  90. 7.15.5 Owlin Recent Developments
  91. 7.16 Dilisense GmbH
  92. 7.16.1 Dilisense GmbH Company Information
  93. 7.16.2 Dilisense GmbH Business Overview
  94. 7.16.3 Dilisense GmbH PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Dilisense GmbH PEPs and Sanction Screening Product Portfolio
  96. 7.16.5 Dilisense GmbH Recent Developments
  97. 7.17 Fenergo
  98. 7.17.1 Fenergo Company Information
  99. 7.17.2 Fenergo Business Overview
  100. 7.17.3 Fenergo PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Fenergo PEPs and Sanction Screening Product Portfolio
  102. 7.17.5 Fenergo Recent Developments
  103. 7.18 Thirdfort
  104. 7.18.1 Thirdfort Company Information
  105. 7.18.2 Thirdfort Business Overview
  106. 7.18.3 Thirdfort PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Thirdfort PEPs and Sanction Screening Product Portfolio
  108. 7.18.5 Thirdfort Recent Developments
  109. 7.19 Experian
  110. 7.19.1 Experian Company Information
  111. 7.19.2 Experian Business Overview
  112. 7.19.3 Experian PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Experian PEPs and Sanction Screening Product Portfolio
  114. 7.19.5 Experian Recent Developments
  115. 7.20 AU10TIX
  116. 7.20.1 AU10TIX Company Information
  117. 7.20.2 AU10TIX Business Overview
  118. 7.20.3 AU10TIX PEPs and Sanction Screening Revenue and Gross Margin (2021-2026)
  119. 7.20.4 AU10TIX PEPs and Sanction Screening Product Portfolio
  120. 7.20.5 AU10TIX Recent Developments
8 North America
  1. 8.1 North America PEPs and Sanction Screening Revenue (2021-2032)
  2. 8.2 North America PEPs and Sanction Screening Revenue by Type (2021-2032)
  3. 8.2.1 North America PEPs and Sanction Screening Revenue by Type (2021-2026)
  4. 8.2.2 North America PEPs and Sanction Screening Revenue by Type (2027-2032)
  5. 8.3 North America PEPs and Sanction Screening Revenue Share by Type (2021-2032)
  6. 8.4 North America PEPs and Sanction Screening Revenue by Application (2021-2032)
  7. 8.4.1 North America PEPs and Sanction Screening Revenue by Application (2021-2026)
  8. 8.4.2 North America PEPs and Sanction Screening Revenue by Application (2027-2032)
  9. 8.5 North America PEPs and Sanction Screening Revenue Share by Application (2021-2032)
  10. 8.6 North America PEPs and Sanction Screening Revenue by Country
  11. 8.6.1 North America PEPs and Sanction Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America PEPs and Sanction Screening Revenue by Country (2021-2026)
  13. 8.6.3 North America PEPs and Sanction Screening Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe PEPs and Sanction Screening Revenue (2021-2032)
  2. 9.2 Europe PEPs and Sanction Screening Revenue by Type (2021-2032)
  3. 9.2.1 Europe PEPs and Sanction Screening Revenue by Type (2021-2026)
  4. 9.2.2 Europe PEPs and Sanction Screening Revenue by Type (2027-2032)
  5. 9.3 Europe PEPs and Sanction Screening Revenue Share by Type (2021-2032)
  6. 9.4 Europe PEPs and Sanction Screening Revenue by Application (2021-2032)
  7. 9.4.1 Europe PEPs and Sanction Screening Revenue by Application (2021-2026)
  8. 9.4.2 Europe PEPs and Sanction Screening Revenue by Application (2027-2032)
  9. 9.5 Europe PEPs and Sanction Screening Revenue Share by Application (2021-2032)
  10. 9.6 Europe PEPs and Sanction Screening Revenue by Country
  11. 9.6.1 Europe PEPs and Sanction Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe PEPs and Sanction Screening Revenue by Country (2021-2026)
  13. 9.6.3 Europe PEPs and Sanction Screening Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China PEPs and Sanction Screening Revenue (2021-2032)
  2. 10.2 China PEPs and Sanction Screening Revenue by Type (2021-2032)
  3. 10.2.1 China PEPs and Sanction Screening Revenue by Type (2021-2026)
  4. 10.2.2 China PEPs and Sanction Screening Revenue by Type (2027-2032)
  5. 10.3 China PEPs and Sanction Screening Revenue Share by Type (2021-2032)
  6. 10.4 China PEPs and Sanction Screening Revenue by Application (2021-2032)
  7. 10.4.1 China PEPs and Sanction Screening Revenue by Application (2021-2026)
  8. 10.4.2 China PEPs and Sanction Screening Revenue by Application (2027-2032)
  9. 10.5 China PEPs and Sanction Screening Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia PEPs and Sanction Screening Revenue (2021-2032)
  2. 11.2 Asia PEPs and Sanction Screening Revenue by Type (2021-2032)
  3. 11.2.1 Asia PEPs and Sanction Screening Revenue by Type (2021-2026)
  4. 11.2.2 Asia PEPs and Sanction Screening Revenue by Type (2027-2032)
  5. 11.3 Asia PEPs and Sanction Screening Revenue Share by Type (2021-2032)
  6. 11.4 Asia PEPs and Sanction Screening Revenue by Application (2021-2032)
  7. 11.4.1 Asia PEPs and Sanction Screening Revenue by Application (2021-2026)
  8. 11.4.2 Asia PEPs and Sanction Screening Revenue by Application (2027-2032)
  9. 11.5 Asia PEPs and Sanction Screening Revenue Share by Application (2021-2032)
  10. 11.6 Asia PEPs and Sanction Screening Revenue by Country
  11. 11.6.1 Asia PEPs and Sanction Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia PEPs and Sanction Screening Revenue by Country (2021-2026)
  13. 11.6.3 Asia PEPs and Sanction Screening Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA PEPs and Sanction Screening Revenue (2021-2032)
  2. 12.2 SAMEA PEPs and Sanction Screening Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA PEPs and Sanction Screening Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA PEPs and Sanction Screening Revenue by Type (2027-2032)
  5. 12.3 SAMEA PEPs and Sanction Screening Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA PEPs and Sanction Screening Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA PEPs and Sanction Screening Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA PEPs and Sanction Screening Revenue by Application (2027-2032)
  9. 12.5 SAMEA PEPs and Sanction Screening Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA PEPs and Sanction Screening Revenue by Country
  11. 12.6.1 SAMEA PEPs and Sanction Screening Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA PEPs and Sanction Screening Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA PEPs and Sanction Screening Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst